Form D · Pharmaceuticals
Relox Medical, LLC
Fort Lauderdale, FL · CIK 0001487006
Offering snapshot reported Mar 29, 2010 · SEC filing
- Reported sold
- $700K Offering amount: $3.5M
- Investors reported
- 2 Form D · investor count
- Minimum accepted
- $50K Reported outside-investor minimum
- First sale
- Mar 15, 2010 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Mar 29, 2010 | Initial | $700,000 | No comparison | 2 | SEC filing |
Offering details
- Securities
- Not reported
- Exemptions
- 06
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-139999
Source: Form D, filed Mar 29, 2010. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Alan Beane | Executive |
| Robert Brown | Executive |
| Kenneth M. Halvorson, Jr. | Executive |
| Mark Roffman, Ph D | Executive |
| Bert Spilker, Ph D, Md | Executive |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
2110 North Ocean Blvd., Unit 14 B
Fort Lauderdale, FL, 33305
Fort Lauderdale, FL, 33305